000538 雲南白藥
按盤價 
52.910 +0.030 (+0.057%)
52.910 +0.030 (+0.057%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 10,774,291 | 2.49% | 39,111,292 | 36,488,373 | 36,373,919 | 32,742,767 | |
| 減：營業總成本 | 8,984,421 | -1.05% | 35,082,750 | 32,087,168 | 31,739,818 | 28,425,125 | |
| 其中:營業成本 | 7,544,467 | -1.12% | 28,744,518 | 26,883,485 | 26,498,435 | 23,655,878 | |
| 財務費用 | (67,221) | 142.08% | (259,244) | (342,878) | (258,281) | (231,946) | |
| 資產減值損失 | 3,998 | -21.13% | (58,128) | (664,339) | (143,220) | (125,480) | |
| 公允價值變動收益 | (19,523) | -118.93% | 123,566 | (619,903) | (1,929,217) | 2,240,369 | |
| 投資收益 | 244,226 | 0.75% | 779,011 | 868,198 | 1,044,401 | 392,173 | |
| 其中：對聯營企業和合營企業的投資收益 | 266,351 | -0.32% | 628,532 | 732,233 | (21,100) | 6,308 | |
| 營業利潤 | 1,918,020 | 10.86% | 4,830,506 | 3,371,279 | 3,485,169 | 6,812,003 | |
| 利潤總額 | 1,919,694 | 11.15% | 4,818,012 | 3,377,002 | 3,481,646 | 6,801,136 | |
| 減：所得稅費用 | 220,648 | 4.36% | 695,451 | 536,593 | 683,986 | 1,290,099 | |
| 淨利潤 | 1,699,046 | 12.09% | 4,122,561 | 2,840,410 | 2,797,661 | 5,511,036 | |
| 減：非控股權益 | (2,885) | 27.38% | 28,779 | (160,716) | (7,256) | (5,036) | |
| 股東淨利潤 | 1,701,931 | 12.12% | 4,093,782 | 3,001,126 | 2,804,917 | 5,516,072 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.950 | 11.76% | 2.290 | 1.900 | 2.210 | 4.320 | |
| 每股派息 (元) * | -- | -- | 2.077 | 1.520 | 1.600 | 3.900 | |
| 每股淨資產 (元) * | 23.140 | 3.87% | 22.194 | 21.428 | 29.800 | 29.789 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 03/06/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
